All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Chimeric Antigen Receptor T-cell (CAR-T) therapy targeting infectious diseases represents an innovative approach to combating a wide range of pathogens. Creative Biolabs has launched a CART development service for infectious diseases, bringing a one-stop solution to your CAR cell therapy.
T cells play a key role in controlling cancer, infectious diseases, and autoimmune diseases, with two main classes of T cells working together to maintain immune homeostasis. The first subset is effector T cells, which are able to eliminate pathogens and tumors. Although effector T cells have the effect of eliminating pathogens and tumors, infectious diseases and tumors have evolved a variety of escape mechanisms to bypass T cell control. The second subset is regulatory T cells (Tregs), which regulate autoimmune responses and also have some limitations in autoimmune diseases.
Fig.1 CAR T cells target different infectious diseases.1
Creative Biolabs provides CAR-T development services for multiple infectious diseases to effectively target and eliminate pathogens. You can click on the type of disease you are interested in below to access the corresponding CART services:
You can learn about our CART development services for infectious diseases through the process below:
CAR T cell therapy targeting infectious diseases represents a promising approach for combatting a wide range of pathogens, with the potential to revolutionize the management and prevention of infectious diseases in the future. Creative Biolabs has always been your trusted partner as a service provider exploring the most cutting-edge of CART cell therapy science. You can deliver your project to us and our scientists will provide you with a complete solution with the most rigorous scientific attitude. Please feel free to contact us, our professional scientists are at your service around the clock!
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION